Figure 7 | Scientific Reports

Figure 7

From: An effective treatment of experimental osteomyelitis using the antimicrobial titanium/silver-containing nHP66 (nano-hydroxyapatite/polyamide-66) nanoscaffold biomaterials

Figure 7

In vivo safety profiles of the TA2-nHP66 scaffold implant in a rabbit model of experimental osteomyelitis.

(A) Silver concentrations of different tissues and organs at different time points of TA2-nHP66 scaffold implantation (after of the debridement surgery). (B) H & E histologic evaluation of liver (a & b low and high magnifications) and kidney (c & d low and high magnifications) retrieved from the TA2-nHP66 scaffold implant group at 12 weeks after the debridement surgery.

Back to article page